Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Aasum, Ellen ^a   Belke, Darrell D ^b   Severson, David L ^b   Riemersma, Rudolph A ^a,c   Cooper, Marie ^a   Andreassen, Morten ^a   Larsen, Terje S ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Isolated working mouse hearts; Substrate oxidation

Indexed keywords

BM 17 0744; FATTY ACID; GLUCOSE; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLYCOLYSIS; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; METABOLIC DISORDER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036352058     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00226.2001     Document Type: Article

References (41)

1. Pyruvate reverses fatty-acid-induced dpression of ventricular function and calcium overload after hypothermia in guinea pig hearts
2. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth
3. PPAR signaling in the control of cardiac energy metabolism
4. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
5. Glucose and fatty acid metabolism in the isolated working mouse heart
6. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPAR delta ligands produce distinct biological effects
7. Free fatty acids and pathogenesis of type 2 diabetes mellitus
8. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha
9. The effects of hypothalamics lesions in genetically diabetic mice
10. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha
11. The cardiac phenotype induced by PPARalpha over-expression mimics that caused by diabetes mellitus
12. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
13. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study)
14. Primary myocardial disease in the diabetic mouse. An ultrastructural study
15. Insulin resistance and cardiovascular disease
16. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
17. Cardiovascular disease in diabetes mellitus type 2: A potential role for novel cardiovascular risk factors
18. Roles of PPARs in health and disease
19. Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice
20. The isolated working mouse heart: Methodological considerations
21. Developmental changes in energy substrate use by the heart
22. Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPAR alpha)
23. Omega-substituted alkyl carboxylic acids as antidiabetic and lipid-lowering agents
24. Cardiovascular dysfunction in insulin-dependent and non-insulin-dependent animal models of diabetes mellitus
25. BM 17.0744: A structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity
26. Pathophysiology of insulin resistance in human disease
27. Metabolic disturbances in diabetic cardiomyopathy
28. The energy substrate switch during development of heart failure: Gene regulatory mechanisms
29. Cardiac consequences of diabetes mellitus
30. Regulation of energy substrate metabolism in the diabetic heart
31. Ventricular energetics
32. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system
33. Peroxisome proliferator-activated receptors: From transcriptional control to clinical practice
34. Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease
35. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes
36. Effects of fatty acids on uncoupling protein-2 expression in the rat heart
37. The influence of age and dietary conditions on diabetes in the db mouse
38. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-gamma activation
39. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor alpha in the adult rodent heart
40. Lipotoxic heart disease in obese rats: Implications for human obesity